COPD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 40 years of age or older.
- People who have smoked at least 10 pack-years (for example, one pack per day for 10 years, or two packs per day for 5 years).
- People who have been recently diagnosed with chronic obstructive pulmonary disease (COPD), a lung condition that makes it hard to breathe, with specific breathing test results falling within a certain range (confirm with trial site for exact values).
Who may not be able to join:
- People who currently have an active lung infection.
- People who have had lung cancer, either currently or in the past.
- People who have a genetic condition called alpha-1 antitrypsin deficiency, which can cause lung and liver problems.
- People who have been diagnosed with interstitial lung disease, a group of conditions that cause scarring of the lungs.
- People who have previously been diagnosed with asthma.
- People who have been diagnosed with chronic hypercapnic respiratory failure, a condition where the lungs cannot remove enough carbon dioxide from the body.
- People who are currently being treated with steroid tablets or injections (known as systemic glucocorticoids).
- People who have an unstable heart condition affecting blood supply to the heart.
- People who are pregnant.
- People who currently have an irregular heartbeat (cardiac arrhythmia).
- People who have high blood pressure that is not well controlled.
- People who have dementia or another condition that affects their ability to give informed consent to participate.
- People who have other medical conditions that the trial doctor considers would make participation unsuitable.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Skaidrius Miliauskas, PhD, Prof., Lithuanian University of Health Sciences, Medical Academy, Department of Pulmonology
Phone: +37037326269
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in oxygen uptake at peak exercise after 12 weeks of dual bronchodilation; Change in health-related quality of life after 12 weeks of dual bronchodilation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.